Daily BriefsSouth Korea

Daily Brief South Korea: Nongshim Co Ltd, Ecopro BM , Korea Zinc and more

In today’s briefing:

  • Nongshim’s Thriving Collaboration with K-Pop Demon Hunters
  • Side Flow Trade Opportunity from the PRS Deal: Timing the Ecopro BM Buy Flow
  • Korea Zinc (010130 KS): TC/RC Recovery Sets Stage for Earnings Re-Rating


Nongshim’s Thriving Collaboration with K-Pop Demon Hunters

By Douglas Kim

  • K-Pop Demon Hunters (KDH) started streaming on Netflix on 20 June 2025. KDH has become the most watched film on Netflix history, achieving 291.5 million views as of 11 September. 
  • Nongshim has a collaboration with Netflix, releasing ramyun and snacks featuring characters from K-Pop Demon Hunters. The sale of these products (especially overseas) are likely to result in higher sales.
  • Nongshim has hit a big home run in this collaboration with Netflix and the K-Pop Demon Hunters film. Additional series related to KDH are highly likely. 

Side Flow Trade Opportunity from the PRS Deal: Timing the Ecopro BM Buy Flow

By Sanghyun Park

  • Ecopro’s PRS: KRW 700bn, 2-year, BM shares underlying, 5.85% coupon; SK’s July PRS was bigger (KRW 1.4tn, 3-year, 4.3%), same payoff mechanics.
  • Watch for hedge-flow side trades: Ecopro’s KRW 700bn PRS on BM shares should mirror SKI’s setup, likely triggering a noticeable pop when the primary buyer hedges.
  • PRS likely hits Sept 24–25; Mirae Asset leads. Be ready to catch flow-driven whipsaws from local institutions around execution.

Korea Zinc (010130 KS): TC/RC Recovery Sets Stage for Earnings Re-Rating

By Rahul Jain

  • Recent News: CZSPT’s Sep 9 guidance points to imported zinc concentrate treatment charges of US$120-140/dmt for Q4, and Bloomberg confirms Chinese smelters are tightening terms.
  • Impact: This rebound in TC/RC levels should lift Korea Zinc’s EBITDA by approximately US$100-135 million, representing a ~5-7% earnings upside over current troughs.
  • Valuation: On normalized earnings, Korea Zinc could re-rate to 8–9× EV/EBITDA. At $120–150/dmt TCs, this points to ~20–50% upside, with further headroom if multiples expand alongside earnings recovery.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars